IMMX Earnings

Quarterly EPS
$-0.24
Q3 2024
$-0.15
Q4 2024
$-0.15
Q1 2025
$-0.22
Q2 2025
$-0.24
Q3 2025
$-0.27
Q4 2025
$-0.18
Q1 2026
$-0.18
Q2 2026
Latest RevenueN/A
Latest Net Income-11557002
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.180-11557002+18.2%
Q1 2026-$0.180-10086687-20.0%
Q4 2025-$0.270-10687830-80.0%
Q3 2025-$0.240-7585692+0.0%
Q2 2025-$0.220-6622563-46.7%
Q1 2025-$0.150-4542528+31.8%
Q4 2024-$0.150-4812054+34.8%
Q3 2024-$0.240-7149395-4.3%
Q2 2024-$0.150-4405850
Q1 2024-$0.220-5331064
Q4 2023-$0.230-5155366
Q3 2023-$0.230-4343912
Immix Biopharma (IMMX) — Earnings